Trial results for the Personal Patient Profile - Bladder Cancer (P3-BC) decision support tool were posted on ClinicalTrials.gov on 2026-04-24, indicating that 71.4% of participants agreed to its use.
Background
Bladder cancer patients undergoing radical cystectomy and urinary diversion face complex decisions regarding their care. There is an identified need for personalized, value-based decisional tools to enhance communication with physicians, facilitate shared decision making, and prepare patients for disease management and follow-up care. The Personal Patient Profile - Bladder Cancer (P3-BC) intervention was developed to address these specific challenges, aiming to improve the patient experience during a critical treatment phase.
Trial design
This completed pilot randomized feasibility study, designated as Phase NA, enrolled 24 participants with Bladder Cancer. The intervention, named the Personal Patient Profile - Bladder Cancer (P3-BC), was designed as a personalized, value-based decisional tool. The study aimed to provide evidence of the feasibility and acceptability of the P3-BC tool, guiding further research and development.
Key results
The trial reported several key measurements related to the acceptability of the Personal Patient Profile - Bladder Cancer (P3-BC) intervention:
- For the outcome "Percent of Participants Who Agree Using the Acceptability Scale" in the "Intervention (P3-BC) Usual Care" group, reported percentages included: 71.4%, 62.5%, 62.5%, 62.5%, 62.5%, 62.5%, 62.5%, 62.5%, 50.0%, 50.0%, 50.0%, and 37.5%.
- Additionally, for the outcome "Number of Participants Who Agree or Disagree With Statements on the Acceptability E-scale", 6 participants were reported to agree.
What this means
The posted results provide initial insights into the feasibility and acceptability of the Personal Patient Profile - Bladder Cancer (P3-BC) decision support tool for patients with bladder cancer. The reported percentages from the acceptability scale, ranging from 37.5% to 71.4% agreement, along with the count of participants who agreed with statements on the acceptability E-scale, offer preliminary data on how patients perceive the tool. These findings are crucial for informing further refinement and larger-scale evaluation of the P3-BC intervention, which aims to improve shared decision-making and patient preparation for complex bladder cancer treatments.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT05033067, titled "The Personal Patient Profile Decision Support for Patients With Bladder Cancer", were posted on 2026-04-24 on clinicaltrials.gov.